MedPath

Hyperchloremia and hypochloremia as predictor of increased mortality,morbidity and AKI in critically ill patients.

Not Applicable
Registration Number
CTRI/2023/06/053412
Lead Sponsor
Sterling Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patient aged above 18 years, regardless of sex of the patients.

2) All Patients admitted to IRCU Sterling Hospital having hypotension requiring inotropic support.

3)All patients requiring either invasive or non-invasive vantilatory support.

Exclusion Criteria

1) Patients aged below 18 years regardless of sex will be excluded.

2) Patients likely to stay less than 24hr in ICU.

3)Patient not requiring either of inotropic support or vantilatory support.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) To study the role of dyschloremia as a marker of increased mortality and morbidity. <br/ ><br>2) Incidence of AKI in critically ill patient with dyschloremia.Timepoint: Chloride level will be measured on the day of requirement of inotropic support or ventilatory support.
Secondary Outcome Measures
NameTimeMethod
Incidence of dyschloremia in disease involving different systems.Timepoint: Any time during hospital admission.
© Copyright 2025. All Rights Reserved by MedPath